Trial NCT01038752

View at ClinicalTrials.gov 
Org. Study IDs: Optimum-Suramin-1

Last trial update was posted on 2015-05-21

MeSH Interventions

Carboplatin Docetaxel Suramin

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated prematurely due to the loss of follow-up of 6 of 14 participants before progression and slow accrual. Due to the resulting small numbers, no analysis was attempted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID